City

New York (1)

Condition

Hypertensive Nephrosclerosis (2)

Chronic Renal Insufficiency (1)

Diabetic Nephropathy (1)

Focal Segmental Glomerulosclerosis (1)

Glomerulonephritis, Membranous (1)

Glomerulopathy (Obesity-associated) (1)

IgA Nephropathy (1)

Proteinuric Kidney Disease (1)

Overall Status

Completed (1)

Terminated (1)

Sign in for free

Phase

phase 3 (1)

phase 4 (1)

Sponsor

Columbia University (1)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)

Collaborator

Novartis Pharmaceuticals (1)

The Cleveland Clinic (1)

Intervention

aliskiren (1)

amlodipine (1)

map goal 102-107 mm hg (1)

map goal less than or equal to 92 mm hg (1)

metoprolol (1)

ramipril (1)

valsartan (1)

Study Documents

Intervention Type

drug (2)

other (1)

Funder Type

NIH (1)

Other (1)

Study Type

Interventional (2)

hypertensive nephrosclerosis

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Hypertensive Nephrosclerosis, Chronic Renal Insufficiency Trial (MAP goal less than or equal to 92 mm Hg, MAP goal 102-107 mm

Completed

Hypertensive Nephrosclerosis
Chronic Renal Insufficiency

MAP goal less than or equal to 92 mm Hg
+4 more

(no location specified)

Apr 23, 2020

Proteinuric Kidney Disease, Diabetic Nephropathy, Hypertensive Nephrosclerosis Trial in New York (Aliskiren, Valsartan)

Terminated

Has Results

Proteinuric Kidney Disease
+6 more

New York, New York

Columbia University Medical Center

Apr 16, 2014